Posted on May 13, 2009 by cartier@bio
Is your life sciences company led by women?
Springboard Enterprises is looking for women-led science companies to present at AllThingsLifeSciences 2009 — a venture forum showcasing early and later stage biotech, medical device, health care IT, products & services and other life science companies.
According to Venture-Catalyst Springboard Enterprises, it is
“the go-to organization for information about and [...]
Filed under: venture capital | Tagged: VC | Leave a Comment »
Posted on April 6, 2009 by cartier@bio
A new regional investor angel fund has sprouted up in the New England area — Mass Medical Angels (MA2) is devoting all of its funds to backing life science startups. The group says its focus is on early stage life science companies looking to raise $250K to $3.0M.
According to the group’s website
Depending on the amount [...]
Filed under: SBIR, venture capital | Tagged: biotech, venture capital | Leave a Comment »
Posted on April 2, 2009 by cartier@bio
The economic news this week wasn’t all doom and gloom – Google announced Google Ventures, a new venture capital fund that will finance biotechnology start ups, among other things.
According to Google Blog:
At its core, Google Ventures is charged with finding and helping to develop exceptional start-ups. We’ll be focusing on early stage investments across [...]
Filed under: BIO, In the News, venture capital | Tagged: biotechnology, Google, Innovation, start-up, VC, venture capital | Leave a Comment »
Posted on December 10, 2008 by cartier@bio
Today we have a guest blogger. Welcome Afif Ghannoum!
In these trying economic times, biotech entrepreneurs are being put to the test to not only raise capital, but just to survive. Start-ups that a year or two ago would have been flush with capital from several sources, have been forced to closely monitor their burn rates [...]
Filed under: Congress, venture capital | Tagged: biotech, economy, entrepreneuer, SBIR, venture capitalist | 3 Comments »
Posted on November 6, 2008 by cartier@bio
Canopy Group announces the launch of BizCafé, a unique website matching life science and high tech entrepreneurs with business opportunities, at www.IndianaBizCafe.com. The BizCafé automatically matches entrepreneurs, investors, and industry experts with opportunities and each other. The BizCafé is a one-stop shop for SBIR/STTR grants and federal procurement; it captures 99% of all available feeds, [...]
Filed under: In the News, venture capital | Leave a Comment »
Posted on September 19, 2008 by cartier@bio
Massachusetts, a state with a large emerging biotechnology company sector, continues to discuss the Small Business Innovation Research Program and who is in and who is out. With the current state of the economy, the U.S. should be working harder than ever to form successful public/private partnerships that will encourage growth and stability in the [...]
Filed under: BIO, SBIR, venture capital | Tagged: BioMed, biotech, Massachusetts, SBIR | Leave a Comment »
Posted on September 2, 2008 by cartier@bio
On August 22, The Boston Globe ran an editorial discussing the SBIR bill created by Senator Kennedy, stating:
Kennedy and Rudman created the program because the work of small companies was often considered too risky and too preliminary to attract venture capital money. Supporters of the program fear that the House bill will dampen the kind [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: Congress, SBIR, Senator Kennedy | 1 Comment »
Posted on August 19, 2008 by cartier@bio
Stories are appearing nationally that highlight the importance of SBIR funding in partnership with venture capital dollars on local economies. These investment capital/government funding partnerships can foster growth in the biotech industry. This is the best way to ensure that our scientists are able to develop cutting-edge treatments and therapies and bring them to the [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, biotech, Kansas City, Kansas Enterprise Technology Corp, Rep. Graves, SBIR, Senate, Senator Bond | Leave a Comment »
Posted on August 18, 2008 by cartier@bio
In St. Louis, another small biotech firm is contemplating what steps to take if the SBIR bill is not renewed soon. Currently, Kereos Inc., a 15-employee company studying promising new methods of detecting and treating cancer is excluded from the SBIR program. This piece in Sunday’s St. Louis Post Dispatch illustrates the struggles that many [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: SBIR, BIO, biotech, VC, House Small Business Committee, Senate, Mark Heesen | Leave a Comment »
Posted on August 11, 2008 by cartier@bio
The Senate Small Business Committee has passed an SBIR reauthorization bill. We hope the House and Senate will work together to pass a final reauthorization bill before this program is set to expire on September 30, 2008.
From the Puget Sound Business Journal:
Under a compromise negotiated in the U.S. Senate, small companies that are majority-owned [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, Biotechnology industry, Jim Greenwood, NIH, SBA, SBIR, Senate Small Business Committee, VC, vc-owned firms | 1 Comment »